1.
Megias-Vericat JE, Martínez-Cuadrón D, Martínez López J, Bergua JM, Tormo M, Serrano J, González A, Pérez de Oteyza J, Vives S, Vidriales B, Herrera P, Vera JA, López Martínez A, De la Fuente A, Amador ML, Hernández-Rivas J Ángel, Fernández M Ángeles, Cerveró CJ, Morillo D, Hernández Campo P, Gorrochategui J, Primo D, Rojas JL, Guenova M, Ballesteros J, Sanz M Ángel, Montesinos P. DIFFERENCES IN EX-VIVO CHEMOSENSITIVITY TO ANTHRACYCLINES IN FIRST LINE ACUTE MYELOID LEUKEMIA. Mediterr J Hematol Infect Dis [Internet]. 2019 Feb. 26 [cited 2021 May 11];11(1):e2019016. Available from: https://www.mjhid.org/index.php/mjhid/article/view/2019.016